- Home
- ALDX vs GROW Comparison
ALDX vs GROW Comparison
Compare ALDX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALDX | GROW |
|---|---|---|
| Founded | 2004 | 1968 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2M | 32.7M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALDX | GROW |
|---|---|---|
| Price | $0.64 | $2.65 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 11.2K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 3.42% |
| EPS Growth | 40.43 | ★ 900.00 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $14,399,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.98 |
| Revenue Growth | N/A | ★ 32.77 |
| 52 Week Low | $0.63 | $2.23 |
| 52 Week High | $5.93 | $3.65 |
Technical Indicators
Market Signals| Indicator | ALDX | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 26.32 | 29.19 |
| Support Level | N/A | $2.45 |
| Resistance Level | $1.58 | $2.75 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 7.12 | 20.25 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.